Skip to main content
Tech.euFundingExplorerBeta

Cardior Pharmaceuticals

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

Cardior Pharmaceuticals has raised €64M across 1 funding round from 9 investors, most recently a Series B round in Aug 2021. Based in Hanover, Germany; active in Healthtech. Data as of 28 Oct 2026.

Hanover, Germanycardior.de ↗
Healthtech
← All companies
Total raised
€64M
€64,000,000
Funding rounds
1
Investors
9
distinct backers
Active since
2021-08
latest 2021-08

Funding by year

EUR raised per year
Cardior Pharmaceuticals — funding by year — interactive chart.
Data table
Cardior Pharmaceuticals — funding by year
2021€64M

Signals

High confidence
Raise-next likelihood9
base rate 48% for Series B
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2021-08-25Series B€64MBioMedPartners,Bristol Myers Squibb,Coparion,FundPlus,Hadean Ventures,High-Tech Gründerfonds (HTGF)+3 moreView deal →

Investors

9
BioMedPartnersBristol Myers SquibbCoparionFundPlusHadean VenturesHigh-Tech Gründerfonds (HTGF)INKEF CapitalLSPSunstone Capital

Related news

Similar companies

same sector or country

Global coverage: FundingData